[新诊断的急性髓性白血病患者中DTA突变的预后价值]

Hui-Juan Chen1, Yang Cao1, Ying-Jie Miao1

  • 1Department of Hematology, The Third Affiliated Hospital of Soochow University, The First People's Hospital of Changzhou, Changzhou 213003, Jiangsu Province, China.

概括

DNMT3A,TET2和ASXL1 (DTA) 基因的突变与急性髓性白血病 (AML) 患者的预后较差有关. 这些患者往往年龄较大,生存时间较短.